Resolution on the results of scientific-practical conference "Clinical evidence of increasing overall survival in the treatment of metastatic breast cancer", held on 29 November 2014 under the auspices of the Department of health of Moscow
Abstract
Objectives: discussion of modern treatment options for metastatic breast cancer (MBC), the determining of the optimal treatment for subgroups of patients with poor prognosis.
About the Authors
E. T. Bairamov
SBME (CP No. 150) branch №4 of the City polyclinic №11, Moscow healthcare Department
Russian Federation
Russian Federation
A. V. Belonogov
SBM Oncological clinic №2 Moscow healthcare Department
Russian Federation
Russian Federation
V. V. Brusnichkina
SBM Oncological clinic №5 Moscow healthcare Department
Russian Federation
Russian Federation
A. V. Bulakh
SBM City Policlinics №201 Moscow Healthcare Department, branch №1
Russian Federation
Russian Federation
M. Y. Byahov
SBME «MCMC» Moscow Healthcare Department
Russian Federation
Russian Federation
S. N. Gurov
SBME Oncological clinic №1 Moscow Healthcare Department
Russian Federation
Russian Federation
G. G. Eremeev
SBM City Policlinics №8 Moscow Healthcare Department
Russian Federation
Russian Federation
N. V. Zhukov
SBME "Dmitriy Rogtachev FRCC CHOI" Moscow Healthcare Department
Russian Federation
Russian Federation
L. G. Zhukova
Federal State Scientific Institution "NN Blokhin Russian Cancer Research Center"
Russian Federation
Russian Federation
L. M. Kogonia
SBME M.F. Vladimirskiu Moscow regional research clinical Institute
Russian Federation
Russian Federation
P. V. Koposov
CC « European Medical Center»
Russian Federation
Russian Federation
L. K. Ovchinnikova
SMH MROC, Balashika
Russian Federation
Russian Federation
V. V. Radlevich
SBM Oncological clinic №2 Moscow healthcare Department
Russian Federation
Russian Federation
E. A. Samyshina
SBM Oncological clinic №4 Moscow healthcare Department
Russian Federation
Russian Federation
A. P. Seryakov
SMH MROC, Balashika
Russian Federation
Russian Federation
M. D. Ter-Ovanesov
SBM State City clinic №40 Moscow healthcare Department
Russian Federation
Russian Federation
I. E. Shumskaya
SBME branch №3 (CP № 68) of City Policlinics №117 Moscow healthcare Department
Russian Federation
Russian Federation
References
1. Состояние онкологической помощи населению России в 2013 году./ Под ред. Каприна А.Д., Старинского В.В., Петровой Г.В. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России, 2014.
2. Франк Г.А., Поддубная И.В., Ягудина Р.И., Борисов Д.А. Результаты «Эпидемиологической программы скрининга HER2-статуса у больных раком молочной железы» в Российской Федерации. Современная онкология. 2013; 03.
3. Cortes J., O’Shaughnessy J., Loesch D. et al. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Lancet. 2011; 377: 914-23.
4. Kaufman P.A., Awada A., Twelves C. et al. Phase III, open-label, randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes. Journal of Clinical Oncology. 2015; 20.
5. Twelves C. Cortes J., Vandat L. et al. Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies. Breast Cancer Res Treat. 2014; 148:553–561.
6. Инструкция по медицинскому применению препарата Халавен (РУ ЛП-001782 от 24.07.2012 (с изменениями от 25.11.14г.)).
7. Химиотерапия и таргетная терапия у женщин с распространенным раком молочной железы без экспрессии или с неизвестным статусом рецепторов эпидермального фактора роста человека 2-го типа: практические клинические рекомендации American Society of Clinical Oncology. J Clin Oncol. 2014; 32(9): 3307-31 (репринт).
8. Cardoso F., Costa A., Norton L. et al. ESO-ESMO Advanced Breast Cancer: ESO-ESMO Consensus Guideline. Ann Oncol. 2014. doi: 10.1093/annonc/mdu385
9. Клинические рекомендации по профилактике, диагностике и лечению больных раком молочной железы. Ассоциация онкологов России. ИГ РОНЦ, 2014.
10. Семиглазов В.Ф., Палтуев Р.М., Манихас А.Г. и др. Клинические рекомендации РООМ по лечению метастатического рака молочной железы/ Общероссийская общественная организация «Российское общество онкомаммологов», 2013.
11. Практические рекомендации по лечению злокачественных опухолей Общества онкологов-химиотерапевтов. Под ред. Моисеенко В.М. – 2014; 3.
Review
For citations:
Bairamov E.T., Belonogov A.V., Brusnichkina V.V., Bulakh A.V., Byahov M.Y., Gurov S.N., Eremeev G.G., Zhukov N.V., Zhukova L.G., Kogonia L.M., Koposov P.V., Ovchinnikova L.K., Radlevich V.V., Samyshina E.A., Seryakov A.P., Ter-Ovanesov M.D., Shumskaya I.E. Resolution on the results of scientific-practical conference "Clinical evidence of increasing overall survival in the treatment of metastatic breast cancer", held on 29 November 2014 under the auspices of the Department of health of Moscow. Research and Practical Medicine Journal. 2015;2(2):102-104. (In Russ.)
Views:
867
Email this article 